Monday, April 28, 2025

Latest

Aurora Cannabis Increases US$400 Million At The Market Offering To US$650 Million

Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be increasing its recently completed US$400 million at-the-market offering as the company previously indicated earlier this week. However, instead of the expected US$350 million increase for the program, the company will only be increasing the figure by US$250 million.

It’s unclear why Aurora elected to not utilize the full amount remaining in its previously filed prospectus to conducted a renewed ATM program. However, documents filed this morning by the company with Sedar indicate that the company has made arrangements with Cowen & Co as well as BMO Capital Markets to increase the original US$400 million program to that of US$650 million.

Aurora entered into the amended agreement with the sales agents, as well as CIBC World Markets and AltaCorp Capital on April 15, for which the sales agents will collect a 2% commission for any shares sold via the at the market distribution.

As per the amended prospectus filed, Aurora intends to utilize the proceeds from the sale of equity for 1) working capital, 2) potential future acquisitions, 3) debt repayments, and 4) capital expenditures.

It is believed that the program has commenced effective today. The result is that investors will now see an additional US$250 million in selling inevitably coming their way over the coming months, causing further dilution.

Aurora Cannabis last traded at $0.67 on the NYSE.


Information for this briefing was found via Sedi and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

6 Responses

  1. Wait ti they realize CBD oil will help with Corona Virus! I use everyday without THC and I haves had a fever in over a year!! No more aches and pains.This stuff is the future just got to stand up to big Pharma!!

    1. Why would they? Its a large cash incinerating machine?

      Pot Stock investors are learning the hard way all these companies were is a greenhouse and a piece of paper with a government signature.
      I mean ya, sometimes an expensive greenhouse, but that’s it…

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Aurora Cannabis is the New Champ; But Being Champ Isn’t Cheap

Aurora Cannabis Inc. (TSX:ACB) (NYSE: ACB) filed its year-end earnings for fiscal 2019 Wednesday aftermarket,...

Saturday, September 14, 2019, 07:30:36 AM

Aurora clear winner in Big 5 quarterly results

Three of Canada’s Big 5 cannabis producers have now reported their quarterly earnings this year,...

Tuesday, February 19, 2019, 02:00:30 PM

Aurora Cannabis Converts 99% of $230 Million Convertible Debenture Into 69 Million Shares

Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced this morning that their early conversion option on...

Monday, November 25, 2019, 09:37:40 AM

Aurora Cannabis Replaces CFO, Conducts Reverse Split

Aurora Cannabis (TSX: ACB) is reporting this morning that it is replacing its chief financial...

Tuesday, February 20, 2024, 08:08:27 AM

Nelson Peltz Resigns As Advisor To Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has seen Nelson Peltz resign as a strategic advisor...

Monday, September 28, 2020, 08:54:46 AM